Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients
- 1 July 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 346 (8967) , 69-74
- https://doi.org/10.1016/s0140-6736(95)92110-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- One Thousand Liver Transplants The Lessons LearnedAnnals of Surgery, 1994
- A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2Transplantation, 1994
- Cytomegalovirus Immune Globulin Prophylaxis in Liver TransplantationAnnals of Internal Medicine, 1993
- Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind TrialAnnals of Internal Medicine, 1993
- Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow TransplantAnnals of Internal Medicine, 1993
- A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart TransplantationNew England Journal of Medicine, 1992
- Cytomegalovirus Infection After Liver Transplantation: Clinical Manifestations and Strategies for PreventionClinical Infectious Diseases, 1990
- Clinical Patterns of Cytomegalovirus Disease After Liver TransplantationArchives of Surgery, 1989
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Infections with Cytomegalovirus and Other Herpesviruses in 121 Liver Transplant Recipients: Transmission by Donated Organ and the Effect of OKT3 AntibodiesThe Journal of Infectious Diseases, 1988